Iranian Scientists Indigenize Ganciclovir Drug to Treat Viral Infections
“The drug Ganciclovir is an antiviral drug that is produced in the form of a lyophilized powder in single-dose packages with a strength of 500 mg,” said Foroutan, the deputy managing director of the knowledge-based company.
“The drug is prescribed for the treatment of diseases caused by Cytomegalovirus (CMV) in adults and adolescents aged 12 and older who have a weak immune system,” he added.
Noting that the medication is used to prevent CMV infection after tissue transplantation or during chemotherapy in adults and children, and at birth due to a weak immune system, Foroutan said, “Our company enjoys the capability to produce 50,000 vials of Ganciclovir annually which fully meets the country's needs.”
Ganciclovir, sold under the brand name Cytovene among others, is an antiviral medication used to treat cytomegalovirus (CMV) infections.
Ganciclovir is commonly associated with a range of serious haematological adverse effects. Common adverse drug reactions (≥1% of patients) include granulocytopenia, neutropenia, anaemia, thrombocytopenia, fever, nausea, vomiting, dyspepsia, diarrhea, abdominal pain, flatulence, anorexia, raised liver enzymes, headache, confusion, hallucination, seizures, pain and phlebitis at injection site (due to high pH), sweating, rash, itch, increased serum creatinine and blood urea concentrations.
4155/v
